wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q36411863-09E5FCF6-02F3-478E-99DC-DC22798D34B4
Q36411863-09E5FCF6-02F3-478E-99DC-DC22798D34B4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36411863-09E5FCF6-02F3-478E-99DC-DC22798D34B4
Biodistribution studies with tumor-targeting bispecific antibodies reveal selective accumulation at the tumor site
P2860
Q36411863-09E5FCF6-02F3-478E-99DC-DC22798D34B4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36411863-09E5FCF6-02F3-478E-99DC-DC22798D34B4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
aba4105c213c6fb00d1ed59cd9ca3d4f323ab1d8
P2860
Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.